Kondo H, Fantes F, Kato H, Gautier S, Parel J M
Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, Miami, FL 33101, USA.
Ophthalmic Surg Lasers. 1998 Aug;29(8):669-76.
To evaluate the efficacy of a novel filtering implant, a synthetic meshwork (MESH), with or without heparin or sodium hyaluronate amendment.
Eighteen eyes of 18 rabbits received MESH surgery. The eyes were divided into three subgroups. Six eyes received the MESH implant with no modification (group 1), 6 eyes received MESH saturated with heparin (group 2), and 6 eyes received MESH with sodium hyaluronate administration into the anterior chamber during surgery (group 3). Intraocular pressure (IOP) and outflow facility were measured during a period of 6 months.
The MESH-implanted eyes showed lower IOP and higher outflow facility than control eyes up to postoperative days 119 and 49, respectively (P > .05). Earliest functional failure was seen in group 3 and latest in group 2.
MESH implant surgery showed a long-term efficacy in reducing IOP. The beneficial effects of added heparin were limited. Sodium hyaluronate administration reduced the efficacy of the implant device.
评估一种新型滤过植入物——合成网状物(MESH),在添加或不添加肝素或透明质酸钠的情况下的疗效。
18只兔子的18只眼睛接受了MESH手术。将眼睛分为三个亚组。6只眼睛接受未改性的MESH植入物(第1组),6只眼睛接受用肝素饱和的MESH(第2组),6只眼睛在手术期间向前房内注入透明质酸钠的MESH(第3组)。在6个月的时间内测量眼压(IOP)和房水流出率。
植入MESH的眼睛在术后第119天和第49天之前,眼压分别低于对照眼,房水流出率高于对照眼(P>.05)。最早出现功能衰竭的是第3组,最晚的是第2组。
MESH植入手术在降低眼压方面显示出长期疗效。添加肝素的有益效果有限。注入透明质酸钠降低了植入装置的疗效。